首页> 外文期刊>Journal of Controlled Release: Official Journal of the Controlled Release Society >Spatiotemporal release of BMP-2 and VEGF enhances osteogenic and vasculogenic differentiation of human mesenchymal stem cells and endothelial colony-forming cells co-encapsulated in a patterned hydrogel
【24h】

Spatiotemporal release of BMP-2 and VEGF enhances osteogenic and vasculogenic differentiation of human mesenchymal stem cells and endothelial colony-forming cells co-encapsulated in a patterned hydrogel

机译:BMP-2和VEGF的时空释放增强了人间充质干细胞和内皮集落形成细胞共包裹在图案化水凝胶中的成骨和血管生成分化

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Reconstruction of large bone defects is limited by insufficient vascularization and slow bone regeneration. The objective of this work was to investigate the effect of spatial and temporal release of recombinant human bone morphogenetic protein-2 (BMP2) and vascular endothelial growth factor (VEGF) on the extent of osteogenic and vasculogenic differentiation of human mesenchymal stem cells (hMSCs) and endothelial colony-forming cells (ECFCs) encapsulated in a patterned hydrogel. Nanogels (NGs) based on polyethylene glycol (PEG) macromers chain-extended with short lactide (L) and glycolide (G) segments were used for grafting and timed-release of BMP2 and VEGF. NGs with 12 kDa PEG molecular weight (MW), 24 LG segment length, and 60/40 L/G ratio (P12-II, NG(10)) released the grafted VEGF in 10 days. NGs with 8 kDa PEG MW, 26 LG segment length, and 60/40 L/G ratio (P8-I, NG(21)) released the grafted BMP2 in 21 days. hMSCs and NG-BMP2 were encapsulated in a patterned matrix based on acrylate-functionalized lactide-chain-extended star polyethylene glycol (SPELA) hydrogel and microchannel patterns filled with a suspension of hMSCs + ECFCs and NG-VEGF in a crosslinked gelatin methacryloyl (GelMA) hydrogel. Groups included patterned constructs without BMP2/VEGF (None), with directly added BMP2/VEGF, and NG-BMP2/NG-VEGF. Based on the results, timed-release of VEGF in the microchannels in 10 days from NG(10) and BMP2 in the matrix in 21 days from NG(21) resulted in highest extent of osteogenic and vasculogenic differentiation of the encapsulated hMSCs and ECFCs compared to direct addition of VEGF and BMP2. Further, timed-release of VEGF from NG(10) in hMSC + ECFC encapsulating microchannels and BMP2 from NG(21) in hMSC encapsulating matrix sharply increased bFGF expression in the patterned constructs. The results suggest that mineralization and vascularization are coupled by localized secretion of paracrine signaling factors by the differentiating hMSCs and ECFCs. (C) 2015 Elsevier B.V. All rights reserved.
机译:大的骨缺损的重建受到血管生成不足和骨骼再生缓慢的限制。这项工作的目的是调查时空释放重组人骨形态发生蛋白2(BMP2)和血管内皮生长因子(VEGF)对人间充质干细胞(hMSCs)成骨和血管生成分化程度的影响和内皮细胞集落形成细胞(ECFC)封装在图案化的水凝胶中。基于聚乙二醇(PEG)大分子单体的短链丙交酯(L)和乙交酯(G)链扩链的纳米凝胶(NGs)用于BMP2和VEGF的接枝和定时释放。具有12 kDa PEG分子量(MW),24 LG段长度和60/40 L / G比(P12-II,NG(10))的NG在10天内释放出嫁接的VEGF。具有8 kDa PEG MW,26 LG段长度和60/40 L / G比的NG(P8-I,NG(21))在21天内释放了嫁接的BMP2。将hMSC和NG-BMP2封装在基于丙烯酸酯官能化丙交酯的星形聚乙二醇(SPELA)水凝胶的图案化基质中,并在交联明胶甲基丙烯酸(GelMA)中填充hMSCs + ECFC和NG-VEGF悬浮液的微通道图案)水凝胶。组包括没有BMP2 / VEGF(无),直接添加BMP2 / VEGF和NG-BMP2 / NG-VEGF的模式化构建体。根据结果​​,从NG(10)在10天的微通道中VEGF的定时释放和从NG(21)在21天的基质中BMP2的定时释放导致包封的hMSC和ECFC的成骨和血管生成分化程度最高直接添加VEGF和BMP2。此外,hMSC + ECFC封装微通道中NG(10)的VEGF的定时释放和hMSC封装基体中NG(21)的NG(21)的BMP2的定时释放大大增加了模式构建物中的bFGF表达。结果表明,矿物质化和血管化与旁分泌信号因子的局部分泌有关,这是通过区分hMSC和ECFC来实现的。 (C)2015 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号